Researchers Race to Strip Stem Cells of Cancer Risk

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Contact
Colly Mitchell
Parker H. Petit Institute for Bioengineering and Bioscience
Contact Colly Mitchell
404-894-5982
Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

Aaron Levine Interviewed to Discuss Public Policy

Full Summary:

Researchers race to strip stem cells of cancer risk

The race to craft stem cells that have the virtues, but not the notoriety, of their embryonic brethren faces its final hurdle: becoming safe enough to help patients. Researchers have unveiled a flurry of advances in recent months in the development of "induced pluripotent" stem cells. "Stem cell research pretty clearly has public support, so this is not a hard choice for Obama," says science policy expert Aaron Levine of the Georgia Institute of Technology in Atlanta. But, he cautions, "The opponents will continue to be very vocal."

Read full article

Additional Information

Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Categories
Institute and Campus, Cancer Research, Student and Faculty, Life Sciences and Biology, Research
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
aaron levine, Cancer research, Institute for Bioengineering and Bioscience, obama, Stem Cell Research
Status
  • Created By: Colly Mitchell
  • Workflow Status: Published
  • Created On: Jul 13, 2009 - 8:00pm
  • Last Updated: Oct 7, 2016 - 11:06pm